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located primarily in the RV outflow tract and anterior RV.But, SEA for LVAR-
VOT were located moatly in two areas along the lateral RV base. Although
locations differed, the PGs measured at the SEA were of low magnitude and
were not significantly different between configurations (LVARVOT7.1 + 4.2
V/cm, LVASVC7.4+ 3.0 V/cm).
The locations of SEA leading to VF for sub-threshold DF shocks depend
upon the DF electrode configuration. Regardless of the configuration, SEA
are located where the PG is low and of a similar magnitude. These results
support the upper limit of vulnerability hypothesis for DF.
m1046131 Where is the Best Alternste Implantation Site of
the “Hot Can” Electrode?
Y. Yamanouchi, K.A. Mowrey, D.G. Hills, M.J. Niebauer, P.J.Tchou,
B.L. Wilkoff. Cleveland Clinic Foundation, C/eve/and, OH, USA
The “hot can” (RV to prepectorel ICD) lead system has been shown to defib-
rillate efficiently. A “can” electrode is implanted in the left pectoral site in most
patients. However, in some patients it is impossible or inconvenient to implant
at such a site. Therefore, the purpoiie of this study was to evaluate relative
efficacy of alternative sites for the “hot can” electrode. Methods: Defibrillation
thresholds (DFTs)were evaluated with a “hot can” system in random order
in 7 pigs (34 + 3.6 kg) using five different “can” electrode implantation sites:
right pectoral, left pectoral; left exillary, right upper abdomen and left upper
abdomen. A right ventricular coil was the cathode for the first-phase of the
biphaeic waveform (135 vF, 65/65% tilt) and the DFT wee determined by a
“down-up down-up” protocol. Results: Mean stored energy (joules) at DFT is
ahown in the table below for each “can” electrode aite.
Imdsntationsite of a “hotcan”electrode
Rightpectoral Left pectoral Leftaxillary Rightabdomen Leftabdomen
20.3 & 2.7” 15.9 & 3.8 14.9 + 2.5 32.0 k 3.4** 30.0 * 3.4**
*p <0.01, **p <0.0001 vs left pectoraland left submaxillaryaite.
Conclusions: 1) DFT is depend upon the “hot can” implantation site. 2)
DFT energy waa unchanged in the axilla~ site and 30% increased with right
pectoral placemant. 3) DFT’s for abdominal “hot can” to RV are inferior to
&ctorally placement ICDS.
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m1047141 PET Myocardial Perfusion Imaging SignificantlyRedu~s the Coet of Coronary Diseese
Management
M. Merhige, G. Stem, D. Saiki, T. Houston, V. Shelton. SUNYati3uffa/o,
Buffalo, IW USA
We hypothesized that myocerdial perfusion imaging (MPI) with PET and Rb-
B2resulta in coatsavings incoronafydisease (CAD) management, compared
with SPECT MPI, due to improved test accuracy, ,despite the increased
coat of PET. Accordingly, we compared procedure Costaand outcome8 in
303 sequential patients referred for CAD evaluation with PET MPI, and in
102 patients imaged with SPECT, matched for pretest likelihood of disease
with “CADENZA” aoftware, which incorporate type of chest pain, cardiac
riak factors, comorbid conditions, and previous exerciae test results. Costs
were calculated ueing estimated chargea: SPECT-$1000, PET-$1850,Angio-
$5000, PTCA-$1O,OOO,CABG-$40,000. At least thrae month follow up wee
obtainad in all patients.
There were no deaths in the PET group. One myocardial infarction oc-
curred just prior to angiography, which waa recommended due to a high risk
PET result.
The percentages of angiogrephy, CABG and PTCI for SPECT vs. PET
were: 32.3 va 9.6; 7.8 vs 3.3; and 2.0 vs 1.7 respectively.
n Pretest Probability DiagnosticCoaWl Treatment Cost@f TotalCostFl
SPECT 102 0.38+ 0.14 $2,617.65
PET
$3,333.33 $5,950.96
303 0.37 + 0.17 $2,380.07 $1,724.48 $4,104.55
Conclusion: A management strategy uaing PET-Ml in patients with an in-
termediate risk of CAD results in: reduced angiography and revascularization
procedures, excellent short-term patient outcomea, and a 30% cost-savings
when compared to conventional management with SPECT imaging.
H1047142 SimulteneouaMyocardialBlood Flow Estimation
Using 13N-NH3-PET end the Argon Inert Gas
Technique in Humsne
J. Kotzerke, S. Glafz, G. Glatfing, M. Hoherl, P.Weismullerl,
V. Hombach 1, S.N. Reske. Nuk/ear-medizin, Universikif U/m, Germany
1Inner’sMedizin, Urriversiklt U/m, Germany
Purpose of the study wee to validate the quantification of myocerdial blood
flow (MBF) with 13N-NH3 and positron emission tomography (PET) with
the argon (Ar) ineti gas methode. Estimation of MBF using NH3-PET and
the application of a two compartmental model was validated in animals
using 15H-H20 PET and the microsphere technique. In humans, calculated
values uaing this approach seemed to be reasonable but were not validated.
We investigated 12 patienta (7 male, 5 female) who had undergone
coronary angiography (relevant coronaty stenosea were excluded) and were
suspicious for small vessel disease. MBF waa aimulteneous eeaesaad after
injection of 740+ 110MBq 13N-NH3 using dynamic PET (ECAT931 or ECAT
Exact HR+) and by the argon (Ar) inerf gas method. Meeeurementa were
performed at rest and during vasodilatation (0.80 mg/kg/4 reins diypridamole
or 0.14 mgikg/min adenosine for 15 reins).
In 21 investigations (9 stress, 12 rest) estimation of MBF were successful
for both modalities: flow valuea were 0.98 + 0.16 ml/g/min and 0.90+ 0.24
ml/g/min at rest and 2.23 + 0.97 mlfg/min and 2.32 + 0.73 ml/g/min during
vasodilatation for Ar and PET, respectively.These values are atatisticslly not
different (pairad t test: p=- 0.05). Correlation of both methods was r = 0.a9.
High MBF during rest was due to increased breathing work and excitation
(suspected from a rate pressure product of 9.426 + 2.149). Coronary flow
reserve was 2.3 + 0.9 and 2.9 + 1.4 for Ar and PET, respectively.
For the first time in vivo MBF estimation using NH3-PET and a two com-
partment model was validated with the argon inert gas method in humans.
1047-143 PredictiveVslueof PETBloodFlow/Meteboiiem
Miemstch in Patiente with Type II Diabetes
Mellitus
H. Sch6der, R. Campisi, T. Ohtake, D.H. Moon, C.K. Hoh, J. Czernin,
H.R. Schelbert. UCLA Schcmlof Medicine, Los Angeles, CA, USA
The accuracy of PET blood flow/glucose metabolism imaging for predicting
the pos.trevascularizationimprovement in regional LV function in CAD pe-
tients ranges from 72-MY. in Unselected patients, yet remaina undefined
in those with diabetes mellitus (DM). Therefore, we studied 20 consecutive
patients (mean age 64 + 11 yeara; 8 with DM = group 1; 12 without DM =
group 11)with PET ‘3N-ammonia and ‘aFDG 2 + 2 weeks prior to revascu-
Iarization. Tha LVEF did not differ between both groups (35 + 8Y0 vs. 29
* 7YO),Flow/meta~lism mismatches in the LAD, LCX and RCA te~toriea
were identified by polar map analysis. Regional and global LV function was
determined by 2D echocerdiography 14 + 14 days prior to and 150 + 145
days after revaacularization. Changes in regional wall motion by ? 1 grade
on a acele of 4 (O= akinesis and 3 = normal) were considered significant.
Fifty-two territories were analyzed; 23 were classified as mismatch, 13 se
match and 16 as normal.
Presence of mismatchand improvementin regionalLVfunction
Sena Spac PPV NPV Acc
GrouDI 92”h 63% so% S3% Sl%
GrouL II 38”/4 S7% 50% 80% 74%
LVEF increased from 29 + 6% to 40 + 7% (p c 0.01) in patients with
z 2 mismatch territories but not in patients with only one mismatch terrftoty
(34 k 11% vs. 36+ 10%, p = 0.5). Thus, if ? 2 mismatch territories were
conaiderad a prerequisite for an improvement in LVEF by at Ieaat 5%, the
positive and negative predictive values were 60% and 100% in group I and
67% and 72% in group Il. In conclusion, the predictive accuracy of pET
blood flow/metabolism imaging is maintained in patients with DM. Moreover,
regulation of glucose utilization in reversibly injured myocardium appears to
be presemd by local factors despite insulin resistance.
I 1047-1441 The MeesurementofMYOcardial B,00dFIOw
With Positron Emission Tomography is Highly
Reproducible
R. Lorenzoni, R. Giatri, S.D. Rosen, P.G.Camici. Hammersmith Hospital,
Londorr, UK, CNR /nstitute of Clinical Pfrysio/ogy,Pisa, /ta/y
Positron emission tomography (PET) is considered the gold atandard for the
non-invasive quantification of myocardial blood flow (MBF) in man. However,
aince little is known about the reproducibility of MBF measurements with PET,
we aimed to study baseline and hyperemic MBF twice in the same patients
on two different occasions. Methods: Thirty patients with angiographically
